Cytomegalovirus antibody levels and mortality among hospitalised elderly patients

References

• Ho M. The history of cytomegalovirus and its diseases. Med Microbiol Immunol. 2008;197(2):65–73.
   PubMed Web of Science ®Google Scholar
• Staras SA, Dollard SC, Radford KW, et al. Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clin Infect Dis. 2006;43(9):1143–1151.
   PubMed Web of Science ®Google Scholar
• Chou S. Newer methods for diagnosis of cytomegalovirus infection. Rev Infect Dis. 1990;12Suppl 7 (Suppl 7):S727–S36.
   Google Scholar
• Limaye AP, Kirby KA, Rubenfeld GD, et al. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA. 2008;300(20):2367–2322.
   PubMed Web of Science ®Google Scholar
• Hodson EM, Jones CA, Webster AC, et al. Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. Lancet. 2005;365(9477):2105–2115.
   PubMed Web of Science ®Google Scholar
• Tyms AS, Taylor DL, Parkin JM. Cytomegalovirus and the acquired immunodeficiency syndrome. J Antimicrob Chemother. 1989; 23(suppl A):89–105.
   PubMedGoogle Scholar
• Liu R, Moroi M, Yamamoto M, et al. Presence and severity of Chlamydia pneumoniae and cytomegalovirus infection in coronary plaques are associated with acute coronary syndromes. Int Heart J. 2006;47(4):511–519.
   PubMed Web of Science ®Google Scholar
• Sorlie PD, Nieto FJ, Adam E, et al. A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Arch Intern Med. 2000;160(13):2027–2032.
   PubMedGoogle Scholar
• Aiello AE, Haan MN, Pierce CM, et al. Persistent infection, inflammation, and functional impairment in older Latinos. J Gerontol A Biol Sci Med Sci. 2008;63(6):610–618.
   PubMed Web of Science ®Google Scholar
• Aiello AE, Haan M, Blythe L, et al. The influence of latent viral infection on rate of cognitive decline over 4 years. J Am Geriatr Soc. 2006;54(7):1046–1054.
   PubMed Web of Science ®Google Scholar
• Lin WR, Wozniak MA, Wilcock GK, et al. Cytomegalovirus is present in a very high proportion of brains from vascular dementia patients. Neurobiol Dis. 2002;9(1):82–87.
   PubMed Web of Science ®Google Scholar
• Di Benedetto S, Müller L, Rauskolb S, et al. Network topology dynamics of circulating biomarkers and cognitive performance in older Cytomegalovirus-seropositive or -seronegative men and women. Immun Ageing. 2019;16:31–34.
   PubMed Web of Science ®Google Scholar
• Schmaltz HN, Fried LP, Xue QL, et al. Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women. J Am Geriatr Soc. 2005;53(5):747–754.
   PubMed Web of Science ®Google Scholar
• Söderberg-Nauclér C. Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? J Intern Med. 2006;259(3):219–246.
   PubMed Web of Science ®Google Scholar
• Pawelec G, Derhovanessian E, Larbi A, et al. Cytomegalovirus and human immunosenescence. Rev Med Virol. 2009;19(1):47–56.
   PubMed Web of Science ®Google Scholar
• Pawelec G, Koch S, Franceschi C, et al. Human immunosenescence: does it have an infectious component?. Ann NY Acad Sci. 2006;1067:56–65.
   PubMed Web of Science ®Google Scholar
• Strandberg TE, Pitkala KH, Tilvis RS. Cytomegalovirus antibody level and mortality among community-dwelling older adults with stable cardiovascular disease. JAMA. 2009;301(4):380–382.
   PubMed Web of Science ®Google Scholar
• Roberts ET, Haan MN, Dowd JB, et al. Cytomegalovirus antibody levels, inflammation, and mortality among elderly latinos over 9 years of follow-up. Am J Epidemiol. 2010;172(4):363–371.
   PubMed Web of Science ®Google Scholar
• McVoy MA, Adler SP. Immunologic evidence for frequent age-related cytomegalovirus reactivation in seropositive immunocompetent individuals. J Infect Dis. 1989;160(1):1–10.
   PubMed Web of Science ®Google Scholar
• Stowe RP, Kozlova EV, Yetman DL, et al. Chronic herpesvirus reactivation occurs in aging. Exp Gerontol. 2007;42(6):563–570.
   PubMed Web of Science ®Google Scholar
• González-Quijada S, Mora-Simón MJ, Martin-Ezquerro A. Association between serological evidence of past Coxiella burnetii infection and atherosclerotic cardiovascular disease in elderly patients. Clin Microbiol Infect. 2014;20(9):873–878.
   PubMed Web of Science ®Google Scholar
• González-Quijada S, Salazar-Thieroldt E, Mora-Simón MJ. Persistent Q fever and ischaemic stroke in elderly patients. Clin Microbiol Infect. 2015;21(4):362–367.
   PubMed Web of Science ®Google Scholar
• Rothman KJ, Greenland S (eds.). Modern epidemiology. 2nd ed. Philadelphia, PA: Lippincott-Raven; 1998.
   Google Scholar
• Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937–948.
   PubMed Web of Science ®Google Scholar
• Dowd JB, Haan MN, Blythe L, et al. Socioeconomic gradients in immune response to latent infection. Am J Epidemiol. 2008;167(1):112–120.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
   PubMedGoogle Scholar
• Limaye AP, 1, Boeckh M. CMV in critically ill patients: pathogen or bystander?. Rev Med Virol. 2010;20(6):372–379.
   PubMed Web of Science ®Google Scholar
• Campbell SE, Seymour DG, Primrose WR. A systematic literature review of factors affecting outcome in older medical patients admitted to hospital. Age Ageing. 2004;33(2):110–115.
   PubMed Web of Science ®Google Scholar
• Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69(1):239–241.
   Web of Science ®Google Scholar
• Olsson J, Wikby A, Johansson B, et al. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish Longitudinal OCTO Immune Study. Mech Ageing Dev. 2000;121(1-3):187–201.
   PubMed Web of Science ®Google Scholar
• Wikby A, Nilsson BO, Forsey R, et al. The immune risk phenotype is associated with IL-6 in the terminal decline stage: findings from the Swedish NONA Immune Longitudinal Study of very late life functioning. Mech Ageing Dev. 2006; 127(8):695–704.
   PubMed Web of Science ®Google Scholar
• Savva GM, Pachnio A, Kaul B, et al. Cytomegalovirus infection is associated with increased mortality in the older population. Aging Cell. 2013;12(3):381–387.
   PubMed Web of Science ®Google Scholar
• Matheï C, Adriaensen W, Vaes B, et al. No relation between CMV infection and mortality in the oldest old: results from the Belfrail study. Age Ageing. 2015;44(1):130–135.
   PubMed Web of Science ®Google Scholar
• Gkrania-Klotsas E, Langenberg C, Sharp SJ, et al. Seropositivity and higher immunoglobulin antibody levels against cytomegalovirus are associated with mortality in the population-based European prospective investigation of cancer-Norfolk cohort. Clin Infect Dis. 2013;56(10):1421–1427.
   PubMed Web of Science ®Google Scholar
• Forte E, Zhang Z, Thorp EB, et al. Cytomegalovirus latency and reactivation: an intricate interplay with the host immune response. Front Cell Infect Microbiol. 2020;10:130.
   PubMed Web of Science ®Google Scholar
• Hadrup SR, Strindhall J, Kollgaard T, et al. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J Immunol. 2006;176(4):2645–2653.
   PubMed Web of Science ®Google Scholar
• Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014;69(Suppl 1):S4–S9.
   PubMed Web of Science ®Google Scholar
• Kim J, Kim AR, Shin EC. Cytomegalovirus infection and memory T cell inflation. Immune Netw. 2015;15(4):186–190.
   PubMed Web of Science ®Google Scholar
• Weltevrede M, Eilers R, de Melker HE, et al. Cytomegalovirus persistence and T-cell immunosenescence in people aged fifty and older: a systematic review. Exp Gerontol. 2016;77:87–95.
   PubMed Web of Science ®Google Scholar
• Aberle JH, Puchhammer-Stockl E. Age-dependent increase of memory B cell response to cytomegalovirus in healthy adults. Exp Gerontol. 2012;47(8):654–657.
   PubMed Web of Science ®Google Scholar
• Li H, Weng P, Najarro K, et al. Infection in older women: longitudinal comparisons of CMV DNA IN PERIPHERAL Monocytes, anti-CMV IgG titers, serum IL-6 levels, and CMV pp65 (NLV)-specific CD8(+) T-cell frequencies with twelve year follow-up. Exp Gerontol. 2014;54:84–89.
   PubMed Web of Science ®Google Scholar
• Lindau P, Mukherjee R, Gutschow MV, et al. Cytomegalovirus exposure in the elderly does not reduce CD8 T cell repertoire diversity. J Immunol. 2019;202(2):476–483.
   PubMed Web of Science ®Google Scholar
• Crooke SN, Ovsyannikova IG, Poland GA, et al. Immunosenescence and human vaccine immune responses. Immun Ageing. 2019;16:25–25.
   PubMed Web of Science ®Google Scholar
• Inoue N, Abe M, Kobayashi R, et al. Vaccine development for cytomegalovirus. Adv Exp Med Biol. 2018;1045:271–296.
   PubMed Web of Science ®Google Scholar